We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Berlex Signs License Agreement with GeneGo

News   Mar 16, 2006

 
Berlex Signs License Agreement with GeneGo
 
 
 

RELATED ARTICLES

Alzheimer's Risk Gene Impairs Brain's Immune Cells

News

A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer's disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. These findings pave the way for new, effective treatment approaches for AD. The results were published in Stem Cell Reports.

READ MORE

Transporting an Anti-cancer Agent to Cells Using Nanoparticles

News

Metal-organic frameworks (MOFs) could be used as a platform for delivering a potent anti-cancer agent, called siRNA, to cells.

READ MORE

Targeting Cancer's Diversity and Evolution

News

Scientists have uncovered close-up details of a vital molecule involved in the mix and match of genetic information within cells. This new information could be used to target proteins of this family to combat cancer's diversity and evolution.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE